Robert W. Baird Cuts Intuitive Surgical (NASDAQ:ISRG) Price Target to $600.00

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) had its price objective reduced by equities research analysts at Robert W. Baird from $707.00 to $600.00 in a report issued on Tuesday,Benzinga reports. The brokerage presently has an "outperform" rating on the medical equipment provider's stock. Robert W. Baird's target price suggests a potential upside of 21.83% from the stock's previous close.

Several other brokerages also recently issued reports on ISRG. Jefferies Financial Group raised their price objective on shares of Intuitive Surgical from $475.00 to $575.00 in a research note on Monday, January 27th. Royal Bank of Canada raised their price objective on shares of Intuitive Surgical from $611.00 to $641.00 in a research note on Monday, January 27th. Stifel Nicolaus raised their price objective on shares of Intuitive Surgical from $525.00 to $610.00 and gave the stock a "buy" rating in a research note on Thursday, December 5th. Truist Financial lowered their price objective on shares of Intuitive Surgical from $666.00 to $605.00 and set a "buy" rating on the stock in a research note on Monday, March 17th. Finally, Barclays raised their price objective on shares of Intuitive Surgical from $610.00 to $674.00 in a research note on Monday, January 27th. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and fifteen have given a buy rating to the stock. Based on data from MarketBeat, Intuitive Surgical has a consensus rating of "Moderate Buy" and an average target price of $611.86.

Remove Ads

Intuitive Surgical Stock Up 0.1 %

ISRG stock traded up $0.68 during midday trading on Tuesday, hitting $492.49. 3,367,426 shares of the company traded hands, compared to its average volume of 1,456,466. Intuitive Surgical has a twelve month low of $364.17 and a twelve month high of $616.00. The business has a 50 day simple moving average of $562.24 and a 200-day simple moving average of $531.34. The stock has a market capitalization of $175.41 billion, a price-to-earnings ratio of 76.83, a price-to-earnings-growth ratio of 5.85 and a beta of 1.43.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, CFO Jamie Samath sold 94 shares of Intuitive Surgical stock in a transaction on Wednesday, January 29th. The stock was sold at an average price of $571.11, for a total transaction of $53,684.34. Following the completion of the transaction, the chief financial officer now directly owns 2,630 shares of the company's stock, valued at approximately $1,502,019.30. This trade represents a 3.45 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Robert Desantis sold 11,545 shares of Intuitive Surgical stock in a transaction on Thursday, March 13th. The shares were sold at an average price of $499.22, for a total value of $5,763,494.90. Following the transaction, the executive vice president now directly owns 5,224 shares of the company's stock, valued at approximately $2,607,925.28. The trade was a 68.85 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders sold 33,754 shares of company stock valued at $17,691,621. 0.90% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in ISRG. Atala Financial Inc bought a new position in shares of Intuitive Surgical in the fourth quarter valued at about $25,000. Berbice Capital Management LLC bought a new position in shares of Intuitive Surgical in the fourth quarter valued at about $26,000. Parvin Asset Management LLC bought a new position in shares of Intuitive Surgical in the fourth quarter valued at about $26,000. BankPlus Trust Department bought a new position in shares of Intuitive Surgical in the fourth quarter valued at about $28,000. Finally, Hurley Capital LLC bought a new position in shares of Intuitive Surgical in the fourth quarter valued at about $28,000. 83.64% of the stock is owned by institutional investors.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.